Patent · US Active

Inhibiting agents for Bruton's tyrosine kinase

US11427577B2 · kind B2 · utility

2Cited by
6References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 24, 2021
Grant dateAug 30, 2022
Priority date—
Expiry dateFeb 24, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their use and production.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.